ES2061273T3 - Ensayo para proteinas glicadas de la sangre. - Google Patents

Ensayo para proteinas glicadas de la sangre.

Info

Publication number
ES2061273T3
ES2061273T3 ES91919886T ES91919886T ES2061273T3 ES 2061273 T3 ES2061273 T3 ES 2061273T3 ES 91919886 T ES91919886 T ES 91919886T ES 91919886 T ES91919886 T ES 91919886T ES 2061273 T3 ES2061273 T3 ES 2061273T3
Authority
ES
Spain
Prior art keywords
pct
glycated
glicated
assay
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919886T
Other languages
English (en)
Inventor
Erling Sundrehagen
Frank Frantzen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axis Biochemicals AS
Original Assignee
Axis Biochemicals AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axis Biochemicals AS filed Critical Axis Biochemicals AS
Application granted granted Critical
Publication of ES2061273T3 publication Critical patent/ES2061273T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Abstract

SE PRESENTA UN METODO PARA DESCUBRIR UNA PROTEINA SANGUINEA GLICADA EN UNA MUESTRA, DICHO METODO COMPRENDE LOS PASOS DE A) EFECTUAR OPCIONALMENTE UNA HEMOLISIS DE DICHA MUESTRA PARA LIBERAR LA PROTEINA GLICADA UNIDA A LA CELULA; B) SEPARAR DICHA PROTEINA SANGUINEA GLICADA Y LA CORRESPONDIENTE PROTEINA SANGUINEA NO GLICADA DE DICHA MUESTRA; C) PONER EN CONTACTO DICHA MUESTRA ANTES O DURANTE LA SEPARACION DE DICHAS PROTEINAS GLICADAS Y NO GLICADAS O PONER EN CONTACTO DICHAS PROTEINAS SEPARADAS CON UN PRIMER AGENTE PARA LA FORMACION DE UNA SEÑAL CAPAZ DE UNIRSE A DICHA PROTEINA GLICAL PERO NO A LA CORRESPONDIENTE PROTEINA NO GLICADA; D) OPCIONALMENTE, PONER EN CONTACTO DICHA MUESTRA ANTES O DURANTE LA SEPARACION DE DICHAS PROTEINAS GLICADAS O NO GLICADAS O PONER EN CONTACTO DICHAS PROTEINAS SEPARADAS CON UN SEGUNDO AGENTE FORMADOR DE SEÑAL CAPAZ DE UNIRSE A DICHA PROTEINA GLICADA Y A LA CORRESPONDIENTE PROTEINA NO GLICADA Y; E) PONER DE MANIFIESTO LOS AGENTES FORMADORES DE SEÑAL QUE SE HAN UNIDO A DICHAS PROTEINAS SEPARADAS Y/O QUE NO TIENEN ENLACE CON LA PROTEINA GLICADA O PROTEINA CORRESPONDIENTE NO GLICADA; CON LA CONDICION DE QUE EN DONDE LA PROTEINA GLICADA COMPRENDE HEMOGLOBINA GLICADA DICHO PRIMER AGENTE FORMADOR DE SEÑAL SERA UN ACIDO BORONICO ETIQUETADO CROMOFORO O UNA SAL DEL MISMO QUE TENGA UNA ABSORCION MAXIMA DE ALREDEDOR 600 NM. EN ESTE METODO LA PROTEINA GLICADA QUE SE ETIQUETA POR EL PRIMER AGENTE FORMADOR DE SEÑAL PUEDE SER CUALQUIERA DE LAS PROTEINAS SANGUINEAS. MEDIANTE LA SELECCION APROPIADA DE LAS PROTEINAS BAJO ENSAYO PUEDE OBTENERSE UNA INDICACION DE LA HISTORIA DEL CONTROL DE GLUCOSA EN LA SANGRE DEL PACIENTE A LO LARGO DE UN PERIODO CORTO, MEDIO O LARGO DE TIEMPO (HASTA TRES MESES).
ES91919886T 1990-11-14 1991-11-13 Ensayo para proteinas glicadas de la sangre. Expired - Lifetime ES2061273T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909024771A GB9024771D0 (en) 1990-11-14 1990-11-14 Assay

Publications (1)

Publication Number Publication Date
ES2061273T3 true ES2061273T3 (es) 1994-12-01

Family

ID=10685375

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91919886T Expired - Lifetime ES2061273T3 (es) 1990-11-14 1991-11-13 Ensayo para proteinas glicadas de la sangre.

Country Status (13)

Country Link
US (2) US5506144A (es)
EP (1) EP0557350B1 (es)
JP (1) JP2643027B2 (es)
AT (1) ATE112635T1 (es)
AU (1) AU8866291A (es)
CA (1) CA2096250C (es)
DE (1) DE69104491T2 (es)
DK (1) DK0557350T3 (es)
ES (1) ES2061273T3 (es)
FI (1) FI104519B (es)
GB (1) GB9024771D0 (es)
NO (1) NO311385B1 (es)
WO (1) WO1992008984A1 (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312760A (en) * 1992-06-08 1994-05-17 Modrovich, Ivan Endre Fructosamine reagent and calibrator system
AU1984295A (en) * 1994-03-11 1995-09-25 Abbott Laboratories Cyanide-free reagent and method for the determination of hemoglobin
GB9508278D0 (en) * 1995-04-24 1995-06-14 Axis Biochemicals As Haemoglobin standards
US6162645A (en) * 1997-03-13 2000-12-19 Abbott Laboratories Determination of % glycated hemoglobin
US6316265B1 (en) 1997-03-13 2001-11-13 Abbott Laboratories Determination of % glycated hemoglobin
US5763282A (en) * 1997-03-20 1998-06-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Absorbance assay for the measurement of cornified envelopes using bicinchoninic acid
US6174734B1 (en) * 1997-10-24 2001-01-16 Abbott Laboratories Measurement of glycated hemoglobin
US20020172936A1 (en) * 1998-03-27 2002-11-21 Canter Joseph M. Apparatus and method for disease detection
US6294281B1 (en) 1998-06-17 2001-09-25 Therasense, Inc. Biological fuel cell and method
EP1104257B1 (en) * 1998-08-14 2008-12-10 BioControl Systems, Inc. Detection of contaminants using self-contained devices employing target material binding dyes
DE19843094A1 (de) * 1998-09-21 2000-03-23 Roche Diagnostics Gmbh Verfahren zur Bestimmung von glykiertem Hämoglobin
DE19856433C2 (de) * 1998-12-08 2001-09-13 Aventis Behring Gmbh Verfahren zum spezifischen Nachweis von glykosilierten Proteinen
US7195923B2 (en) * 2001-01-31 2007-03-27 Scripps Laboratories, Inc. Ratiometric determination of glycated protein
CA2435741C (en) * 2001-01-31 2011-05-31 Scripps Laboratories Methods and devices for quantitation of glycated protein
US6677158B2 (en) * 2001-03-14 2004-01-13 Exocell Inc. Method for measurement of glycated hemoglobin by a rapid strip test procedure
US7005273B2 (en) * 2001-05-16 2006-02-28 Therasense, Inc. Method for the determination of glycated hemoglobin
US6562581B2 (en) 2001-08-31 2003-05-13 Portascience Method for quantitative determination of glycated hemoglobin
US7368190B2 (en) * 2002-05-02 2008-05-06 Abbott Diabetes Care Inc. Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods
WO2004042364A2 (en) * 2002-11-05 2004-05-21 Therasense, Inc. Assay device, system and method
US7390670B2 (en) * 2003-02-20 2008-06-24 Lumigen, Inc. Signalling compounds and methods for detecting hydrogen peroxide
US20050037331A1 (en) * 2003-08-13 2005-02-17 William Galbraith Apparatuses and methods for reducing albumin in samples
ATE509275T1 (de) * 2003-09-23 2011-05-15 Epinex Diagnostic Inc Schnelltest für glykiertes albumin
JP4577873B2 (ja) * 2004-04-09 2010-11-10 旭化成ファーマ株式会社 試薬の安定性を改善する方法
AU2005203321A1 (en) * 2004-08-03 2006-02-23 Axis-Shield Diagnostics Limited Assay
US7361513B2 (en) * 2005-04-08 2008-04-22 Streck, Inc. Cellular controls for glycated hemoglobin Hb A1c
US20070015291A1 (en) * 2005-07-18 2007-01-18 Smith Henry J Rapid test for glycated albumin in blood
KR100778889B1 (ko) 2005-07-28 2007-11-28 주식회사 아이센스 전기화학적 당화단백질 검출 시스템
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US20100012049A1 (en) * 2006-04-12 2010-01-21 Jms Co., Ltd Cavitation heating system and method
US20090042237A1 (en) * 2007-08-06 2009-02-12 Henry John Smith Aptamer based point-of-care test for glycated albumin
US8278057B2 (en) * 2007-09-14 2012-10-02 Nestec S.A. Addressable antibody arrays and methods of use
DE102007045335A1 (de) 2007-09-22 2009-04-09 Gesa Raschke Sitz- und Anlehnfläche
US20100167306A1 (en) * 2008-12-26 2010-07-01 Henry John Smith Rapid test for glycated albumin in saliva
US20100213057A1 (en) 2009-02-26 2010-08-26 Benjamin Feldman Self-Powered Analyte Sensor
FR2947632B1 (fr) 2009-07-01 2011-11-11 Sebia Sa Analyse et dosage d'hemoglobines glyquees par electrophorese capillaire, compositions tampon et kits pour electrophorese capillaire
US20130203172A1 (en) * 2012-02-08 2013-08-08 Bio-Rad Laboratories, Inc. Self-contained multi-reagent assay device
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
CN109900908A (zh) * 2014-03-20 2019-06-18 生物辐射实验室股份有限公司 糖化蛋白质试验
EP3191844B1 (en) * 2014-09-08 2022-04-20 Indian Institute Of Science Electrochemical biosensor and a method of sensing albumin and its complexes
EP3050023B1 (en) 2014-10-27 2021-08-25 Aseko, Inc. Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
CA2993275C (en) 2015-08-20 2022-06-21 Aseko, Inc. Diabetes management therapy advisor
CN109154623B (zh) * 2015-12-30 2022-04-05 W健康公司 用于确定血液样本中的HbA1c的量的方法
US10436773B2 (en) 2016-01-18 2019-10-08 Jana Care, Inc. Mobile device based multi-analyte testing analyzer for use in medical diagnostic monitoring and screening
MX2019001016A (es) 2016-07-25 2019-07-04 Gentian As Dispositivo de ensayo y metodo para la evaluacion de celulas sanguineas.
WO2018056762A1 (ko) * 2016-09-22 2018-03-29 주식회사 딕스젠 당화 알부민 측정용 시약 조성물 및 이를 이용한 당화 알부민의 측정방법
KR102029798B1 (ko) * 2016-09-22 2019-10-08 주식회사 딕스젠 당화 알부민 측정용 시약 조성물 및 이를 이용한 당화 알부민의 측정방법
WO2018056761A1 (ko) * 2016-09-22 2018-03-29 주식회사 딕스젠 당화혈색소 측정용 시약 조성물 및 이를 이용한 당화혈색소의 측정방법
KR102029797B1 (ko) * 2016-09-22 2019-10-08 주식회사 딕스젠 당화혈색소 측정용 시약 조성물 및 이를 이용한 당화혈색소의 측정방법
WO2018138139A1 (en) 2017-01-24 2018-08-02 Gentian As Method for assessing cell surface receptors of blood cells
JP7015521B2 (ja) * 2017-11-09 2022-02-03 国立大学法人弘前大学 全血アルブミン分析装置および全血アルブミン分析方法
KR102312321B1 (ko) * 2020-01-03 2021-10-13 주식회사 딕스젠 당화 알부민 측정용 시약 키트 및 이를 이용한 당화 알부민 비율 측정법
KR102341169B1 (ko) * 2020-03-05 2021-12-21 주식회사 딕스젠 당화 알부민 비율 측정용 시약 키트 및 이를 이용한 당화 알부민 비율의 측정방법
US11536732B2 (en) 2020-03-13 2022-12-27 Jana Care, Inc. Devices, systems, and methods for measuring biomarkers in biological fluids

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269605A (en) * 1978-06-28 1981-05-26 Amicon Corporation Method and kit for separation of glycoproteins
US4268270A (en) * 1979-04-30 1981-05-19 Children's Hospital Medical Center Glycosylated hemoglobin measurement
JPS57101765A (en) * 1980-12-17 1982-06-24 Chugai Pharmaceut Co Ltd Method for assaying specific serum protein
IT1167460B (it) * 1981-06-26 1987-05-13 Sclavo Inst Sieroterapeut Dosaggio delle proteine glicosilate in fluidi biologici e mezzi adatti allo scopo
US4701418A (en) * 1984-03-30 1987-10-20 Dianon Systems, Inc. Method for determining lipid bound sialic acid in whole blood
JPS6128865A (ja) * 1984-07-20 1986-02-08 Terumo Corp 浄化血漿中の沈澱剤モニタ方法及びその装置
JPH0775557B2 (ja) * 1986-04-25 1995-08-16 富士レビオ株式会社 脂質結合性シアル酸の測定法
US4797473A (en) * 1986-06-25 1989-01-10 Regents Of The University Of Minnesota Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins
DE3720736A1 (de) * 1987-06-23 1989-01-05 Erwin Dr Schleicher Verfahren, reagenzien und ausruestung zur einfachen bestimmung von nicht-enzymatisch glykosylierten proteinen in koerperfluessigkeiten
US4861728A (en) * 1987-07-24 1989-08-29 Becton, Dickinson And Company Immunoassay of glycosylated hemoglobin using a labeled boron reagent
US5240735A (en) * 1988-09-30 1993-08-31 Miles Inc. Method of manufacturing a test article for the determination of protein
NO890029D0 (no) * 1989-01-04 1989-01-04 Axis Research Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
DE69108439T2 (de) * 1990-05-01 1995-07-27 Nacalai Tesque Inc Verfahren zur Bestimmung des Glykationsprozentsatzes eines bestimmten Proteins.

Also Published As

Publication number Publication date
EP0557350A1 (en) 1993-09-01
US5506144A (en) 1996-04-09
NO931747L (no) 1993-07-14
CA2096250C (en) 2002-09-24
US5919708A (en) 1999-07-06
FI932150A (fi) 1993-06-03
GB9024771D0 (en) 1991-01-02
NO311385B1 (no) 2001-11-19
JPH06502244A (ja) 1994-03-10
DE69104491D1 (de) 1994-11-10
DE69104491T2 (de) 1995-02-16
EP0557350B1 (en) 1994-10-05
AU8866291A (en) 1992-06-11
JP2643027B2 (ja) 1997-08-20
DK0557350T3 (da) 1994-11-07
NO931747D0 (no) 1993-05-13
ATE112635T1 (de) 1994-10-15
FI932150A0 (fi) 1993-05-12
FI104519B (fi) 2000-02-15
CA2096250A1 (en) 1992-05-15
WO1992008984A1 (en) 1992-05-29

Similar Documents

Publication Publication Date Title
ES2061273T3 (es) Ensayo para proteinas glicadas de la sangre.
ES8705633A1 (es) Un metodo de inmunoensayo
NO882299D0 (no) Fremgangsmaate for magnetisk separering av merket reagens i en immunometrisk bindings-analyse.
FR2816410B1 (fr) Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire
DE68929334D1 (de) Verfahren zumm Assay von Endotoxin-Konzentration
ATE120551T1 (de) Analyse der varianten von analyten.
AU3563397A (en) Methods for determining the presence of brain protein s-100
CA2213083A1 (en) Detection of antibody production

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 557350

Country of ref document: ES